Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Brainstorm Cell Therapeutics Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +9 vs. Q1 2022
- Shares held
- 3.97M
- −190.1K (−4.6%) vs. Q1 2022
- Total value
- $11.0M
- −$2.97M (−21.3%) vs. Q1 2022
- New holders
- 11
- 6 more added
- Sold out
- 2
- 17 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCLI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 5 | $1.73K |
| Q2 2025 | 34 | $264.0K |
| Q1 2025 | 32 | $1.09M |
| Q4 2024 | 34 | $560.3K |
| Q3 2024 | 38 | $2.52M |
| Q2 2024 | 48 | $4.09M |
| Q1 2024 | 47 | $2.19M |
| Q4 2023 | 46 | $1.04M |
| Q3 2023 | 53 | $928.4K |
| Q2 2023 | 57 | $11.5M |
| Q1 2023 | 48 | $20.4M |
| Q4 2022 | 43 | $6.16M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 48 | $11.0M |
| Q1 2022 | 39 | $14.0M |
| Q4 2021 | 42 | $17.6M |
| Q3 2021 | 52 | $16.9M |
| Q2 2021 | 57 | $21.4M |
| Q1 2021 | 75 | $32.1M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Brainstorm Cell Therapeutics Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 200 | $0 | 0.00% | −2,178−91.6% | Reduced |
| Westside Investment Management, Inc. | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Mark Sheptoff Financial Planning, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 35 | $0 | 0.00% | +35 | New |
| CoreCap Advisors, LLC | 133 | $0 | 0.00% | +133 | New |
| First Manhattan Co | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 364 | $1.00K | 0.00% | −117−24.3% | Reduced |
| Cypress Capital Management LLC (WY) | 1,000 | $3.00K | 0.00% | +1,000 | New |
| Royal Bank of Canada | 1,533 | $4.00K | 0.00% | 00.0% | Unchanged |
| Washington Trust Co | 2,500 | $7.00K | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 2,634 | $7.00K | 0.00% | +2,634 | New |
| Institutional & Family Asset Management, LLC | 3,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Bangor Savings Bank | 4,000 | $11.0K | 0.00% | +4,000 | New |
| Tower Research Capital LLC (TRC) | 5,544 | $15.0K | 0.00% | +5,544 | New |
| Steward Partners Investment Advisory, LLC | 6,700 | $18.0K | 0.00% | −1,000−13.0% | Reduced |
| Bank of America Corp | 7,611 | $21.0K | 0.00% | +389+5.4% | Added |
| UBS Group AG | 7,795 | $22.0K | 0.00% | +89+1.2% | Added |
| Aptus Capital Advisors, LLC | 10,210 | $28.0K | 0.00% | −2,290−18.3% | Reduced |
| Advisor Group Holdings, Inc. | 10,839 | $31.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 11,528 | $32.0K | 0.00% | −722−5.9% | Reduced |
| Raymond James Financial Services Advisors, Inc. | 11,748 | $32.0K | 0.00% | −283−2.4% | Reduced |
| Charles Schwab Investment Management Inc | 11,287 | $32.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 12,085 | $33.0K | 0.00% | +12,085 | New |
| Susquehanna International Group, LLP | 15,323 | $42.0K | 0.00% | −79,277−83.8% | Reduced |
| HighPoint Advisor Group LLC | 17,033 | $45.0K | 0.00% | +17,033 | New |
| Renaissance Technologies LLC | 17,100 | $47.0K | 0.00% | +17,100 | New |
| Wells Fargo & Company | 17,897 | $50.0K | 0.00% | +1,672+10.3% | Added |
| Virtu Financial LLC | 20,702 | $57.0K | 0.00% | +20,702 | New |
| Group One Trading, L.P. | 24,134 | $67.0K | 0.00% | −24,963−50.8% | Reduced |
| Citadel Advisors LLC | 25,685 | $70.0K | 0.00% | +1,566+6.5% | Added |
| S.C. Financial Services, Inc. | 25,471 | $70.0K | 0.11% | +10,186+66.6% | Added |
| Boothbay Fund Management, LLC | 27,868 | $77.0K | 0.00% | −1,318−4.5% | Reduced |
| Liberty Wealth Management LLC | 30,000 | $82.0K | 0.03% | +30,000 | New |
| IFP Advisors, Inc | 19,850 | $104.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 40,982 | $113.0K | 0.00% | −8,124−16.5% | Reduced |
| Jmac Enterprises LLC | 45,430 | $125.0K | 0.03% | 00.0% | Unchanged |
| Northern Trust Corp | 55,916 | $154.0K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 93,000 | $257.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 96,060 | $265.0K | 0.00% | 00.0% | Unchanged |
| Weaver Consulting Group | 104,653 | $289.0K | 0.16% | −25,347−19.5% | Reduced |
| Millennium Management LLC | 109,996 | $304.0K | 0.00% | −31,257−22.1% | Reduced |
| JPMorgan Chase & Co | 187,070 | $516.0K | 0.00% | −59,132−24.0% | Reduced |
| Raymond James & Associates | 187,403 | $517.0K | 0.00% | −3,000−1.6% | Reduced |
| Ikarian Capital, LLC | 253,432 | $698.0K | 0.29% | −50,729−16.7% | Reduced |
| Abner Herrman & Brock LLC | 265,000 | $731.0K | 0.13% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 275,909 | $761.0K | 0.00% | −7,576−2.7% | Reduced |
| BlackRock Inc. | 473,733 | $1.31M | 0.00% | −777−0.2% | Reduced |
| Vanguard Group Inc | 1,427,902 | $3.94M | 0.00% | +6,803+0.5% | Added |
| CFO4Life Group, LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |